COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY

Кардиоваскулярная терапия и профилактика. 2018;17(3):71-78 DOI 10.15829/1728-8800-2018-3-71-78

 

Journal Homepage

Journal Title: Кардиоваскулярная терапия и профилактика

ISSN: 1728-8800 (Print); 2619-0125 (Online)

Publisher: «SILICEA-POLIGRAF» LLC

LCC Subject Category: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system

Country of publisher: Russian Federation

Language of fulltext: Russian

Full-text formats available: PDF

 

AUTHORS

L. N. Uddin (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
M. A. Gabitova (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
A. A. Sokolova (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
N. S. Morozova (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
D. A. Napalkov (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
D. V. Vychuzhanin (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
A. V. Egorov (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)
V. V. Fomin (I. M. Sechenov First Moscow State Medical University of the Ministry of Health)

EDITORIAL INFORMATION

Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 8 weeks

 

Abstract | Full Text

A literature review provided, on the usage of various schemes of perioperational anticoagulation therapy (ACT) in atrial fibrillation patients undergoing scheduled surgery. It is noted that clinicians quite often pass through a situation when patients taking ACT require invasive investigations and surgery. Perioperational management of such category of patients is complicated as, on the one hand, the surgery under ACT is associated with intraoperational hemorrhagic complications, and, on the other hand, ACT cessation might increase the risk of thrombotic complications. The variants assessed, of different periprocedural ACT in patients taking vitamin K antagonists. It was found that as an alternative to continuous ACT recently, bridge therapy with low molecular weight heparins applied, aiming the decrease of the risk of bleeding in adequate thromboprophylaxis. The results of clinical trials provided on the assessment of bridge therapy in surgery. Risk stratification approaches presents for thromboembolic and hemorrhagic complications in surgery.